<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Testosterone dosing regimens for male hypogonadism</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Testosterone dosing regimens for male hypogonadism</h1>
<div class="graphic"><div class="figure"><div class="ttl">Testosterone dosing regimens for male hypogonadism</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Administration route</td> <td class="subtitle1">Preparation</td> <td class="subtitle1">Initial dose</td> <td class="subtitle1">Usual dose range</td> </tr> <tr> <td rowspan="2">IM</td> <td>Solution (testosterone enanthate [eg, Delatestryl<sup>*</sup>], testosterone cypionate [eg, Depo-Testosterone])</td> <td>75 to 100 mg once weekly, <strong>or</strong> 150 to 200 mg every 2 weeks<sup>¶</sup></td> <td>50 to 100 mg once weekly, <strong>or</strong> 100 to 200 mg every 2 weeks<sup>¶</sup></td> </tr> <tr> <td>Solution (testosterone undecanoate [Aveed])</td> <td colspan="2">750 mg; repeat 750 mg dose after 4 weeks, and then every 10 weeks thereafter</td> </tr> <tr class="highlight_lght_gray_text"> <td>Intranasal</td> <td>Gel (Natesto)</td> <td colspan="2">11 mg (2 pump actuations; 1 actuation per nostril) 3 times daily (6 to 8 hours apart)</td> </tr> <tr> <td rowspan="4">Oral</td> <td>Capsule (Jatenzo)</td> <td>237 mg twice daily</td> <td>158 to 396 mg twice daily</td> </tr> <tr> <td>Capsule (Kyzatrex)</td> <td>200 mg twice daily</td> <td>100 mg once daily to 400 mg twice daily (maximum: 800 mg/day)</td> </tr> <tr> <td>Capsule (Tlando)</td> <td>225 mg twice daily</td> <td>Dose is not adjusted; may continue use at fixed dose if serum testosterone concentrations remain within normal range</td> </tr> <tr> <td>Capsule (testosterone <span class="nowrap_whitespace">undecanoate)<sup>*</sup></span></td> <td>120 to 160 mg/day in 2 divided doses for 2 to 3 weeks</td> <td>40 to 120 mg/day</td> </tr> <tr class="highlight_lght_gray_text"> <td>SUBQ (injection)</td> <td>Solution (Xyosted)</td> <td>75 mg once weekly</td> <td>50 to 100 mg once weekly</td> </tr> <tr> <td>SUBQ (implantation)</td> <td>Pellet (Testopel)</td> <td colspan="2">150 to 450 mg every 3 to 6 months</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="4">Topical</td> <td>1% Gel (eg, AndroGel 1%,<sup>*</sup> Testim, Vogelxo)</td> <td>50 mg applied once daily in the morning to the shoulders and/or upper <span class="nowrap_whitespace">arms<sup>Δ◊</sup></span></td> <td>50 to 100 mg/day (maximum: <span class="nowrap_whitespace">100 mg/day)<sup>◊§</sup></span></td> </tr> <tr class="highlight_lght_gray_text"> <td>1.62% Gel (eg, AndroGel 1.62%)</td> <td>40.5 mg applied once daily in the morning to the shoulders and upper <span class="nowrap_whitespace">arms<sup>¥</sup></span></td> <td>20.25 to 81 mg/day (maximum: <span class="nowrap_whitespace">81 mg/day)<sup>¥</sup></span></td> </tr> <tr class="highlight_lght_gray_text"> <td>2% Gel (eg, Fortesta)</td> <td>40 mg (4 pump actuations) applied once daily in the morning to the thighs</td> <td>10 to 70 mg/day (1 to 7 pump actuations; maximum: 70 mg/day)</td> </tr> <tr class="highlight_lght_gray_text"> <td>Transdermal solution</td> <td>60 mg (2 pump actuations) applied once daily in the morning to the axillae</td> <td>30 to 120 mg/day (1 to 4 pump actuations)</td> </tr> </tbody></table></div><div class="graphic_footnotes"><p>IM: intramuscular; 
        SUBQ; subcutaneous.</p>
<p>* Canadian product.</p>
<p>¶ Dosing for this formulation is from the following sources: AUA <span class="nowrap_whitespace">(Mulhall 2018)<sup>[1]</sup>,</span> ES <span class="nowrap_whitespace">(Bhasin 2018)<sup>[2]</sup>.</span></p>
<p>Δ AndroGel 1% and generic equivalents may also be applied to the abdomen.</p>
<p>◊ For the testosterone 1% gel and Vogelxo pump formulations, 1 pump <span class="nowrap_whitespace">actuation = 12.5 mg.</span></p>
<p>§ Maximum dose according to manufacturers of Testim and Vogelxo.</p>

    ¥ For the testosterone 1.62% gel and AndroGel 1.62% pump formulations, 1 pump actuation = 20.25 mg.</div><div class="graphic_reference">References:
    <ol>
<li>Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol 2018; 200:423.</li>
<li>Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2018; 103:1715.</li>
</ol>
<p class="extra_spacing_top">Reproduced from: Lexicomp Online (Lexi-Interact). Copyright © 1978-2024 Lexicomp, Inc. All Rights Reserved.</p></div><div id="graphicVersion">Graphic 94118 Version 15.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
